/
/
/

Glenmark Pharmaceuticals Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)2,472.00
Volume (₹)5.97 L
High (₹)2,482.60
Upper Circuit2,547.90
Low (₹)2,453.60
Lower Circuit2,399.50
Prev Close2,461.40
52W High (₹)2,537.60
Price2,475.00
52W Low (₹)1,792.60

Share Market Cap & Key Ratios Overview

M.Cap (₹)69511.90 Cr
Div. Yield (%)0.10
PE Ratio38.66
Debt to Equity0.00
Price to Book5.75
Book Value371.30
EPS (TTM)63.70
Face Value1.00
ROE (%)14.10

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
GLENMARKNSE
LTP
1W Low
1W High
Market cap (₹)
1865+27.7 (1.51%)
1832.20
1891.50
4,42,437Cr
9624+249 (2.66%)
9312.50
9624
2,48,054Cr
4985+145 (3.00%)
4848.50
4992
1,89,842Cr
1170.1+10.1 (0.87%)
1152.10
1178
1,15,810Cr
1383-11.5 (-0.82%)
1364.50
1405.20
1,11,565Cr
2034+80 (4.09%)
1963.80
2037.20
1,08,338Cr
2465+164.3 (7.14%)
2303
2493
1,02,410Cr
1211.2+26.2 (2.21%)
1185
1222
1,01,163Cr
1721.5-12.5 (-0.72%)
1689.30
1738.90
97,642Cr
2102.8+19.8 (0.95%)
2080
2135
96,950Cr
2475+27.6 (1.13%)
2424
2482.60
69,512Cr

Key Highlights of Glenmark Pharmaceuticals Ltd Balance Sheet

Glenmark Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹28.22Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹28.22Cr, and the reserves and surplus of the company is ₹24117Cr.

The company has its non-current liabilities with total liabilities of ₹34216.1Cr as of 2026-03-31.

The current liabilities are ₹3669.03Cr as of 2026-03-31. At the same time, current assets are ₹6095.1Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹15202.2Cr and tangible assets of ₹2027.9Cr, provided in the Glenmark Pharmaceuticals Ltd financial statements.